上客户端，和病友交流
点击下载
返回
肾癌
Elisabeth Heath M.D.

Elisabeth Heath M.D.

外科
Karmanos cancer center

擅长疾病

临床新药咨询

通过咨询找到适合自己的药物

专家会诊咨询

专业、及时的一对一咨询

如果您的问题未能解决，您还可以选择：

医学顾问

极速问诊

2万名名医
7*24小时为您匹配
1对1

找专家

肿瘤专科专家
对症找医专科专治

专家介绍

2015-06-17 15:341841
 ·         Gender

·         Female

·         Multidisciplinary Team(s)

·         Genitourinary Oncology 

·         Department/Research Program(s)

·         Department of Oncology 

·         Cancer Type(s)

·         Adrenal Cancer 
Bladder cancer 
Kidney Cancer 
Penile Cancer 
Prostate Cancer 
Testicular Cancer 
Ureter Cancer 
Urethra Cancer 

·         Contact Info

·         Email:
heathe@karmanos.org

 

来自 <http://www.karmanos.org/physicians/Elisabeth-Heath?Disease=229&PageIndex=0&SortDirection=1>

 

·         Education

·         Fellowship
Medical oncology Fellowship: Johns Hopkins School of Medicine and Hospital, Baltimore, MD
Medical School
Jefferson Medical College
Residency
Georgetown University School of Medicine and Hospital, Washington, DC
Graduate Training
Jefferson Medical College

·         Professional Memberships/Associations

·         American Society of Clinical Oncology 
American Association for Cancer Research 
Southwest oncology Group 

·         Board Certifications

·         Internal Medicine
American Board of Internal Medicine

·         Clinical Interests

·         Medical Oncology 

·         Research Interests

·         Multidisciplinary care of patients with prostate, kidney, bladder, testicular cancer and Phase I clinical trials. 

·         Awards

·         2011 Blue Cross Blue Shield of Michigan Foundation, McDevitt Excellence in Research Award
2011 Wayne State University, Physician Golden Heart Faculty Award
Detroit's Top Docs, Hour Magazine
2010 NCI Cancer Clinical Investigator Team Leadership Award
2010 The Spirit of Detroit Award

·         Publications

·         First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother Pharmacol. 2011 Oct 22. PMID: 22020315 Authors: Chung V, Heath EI, Schelman WR, Johnson BM, Kirby LC, Lynch KM, Botbyl JD, Lampkin TA, Holen KD.
A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors. Invest New Drugs. 2011 Aug 3. PMID: 21799472 Authors: Heath EI, Forman K, Malburg L, Gainer S, Suttle AB, Adams L, Ball H, Lorusso P.
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction. Anticancer Drugs. 2011 Sep;22(8):794-800. PMID: 21799472 Authors: Gupta S, Parsa V, Heilbrun LK, Smith DW, Dickow B, Heath E, Vaishampayan
Inhibition of HDAC1 by Maspin Abrogates Epigenetic Silencing of Glutathione S-Transferase Pi (GSTp) in Prostate Carcinoma Cells. Mol Cancer Res. 2011 May 26. PMID: 21622623 Authors: Li X, Kaplun A, Lonardo F, Heath EI, Sakr FH, Irish J, Sakr WA, Sheng S.
Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience. J Geriatr Oncol. 2011 Jan 1;2(1):18-24. PMID: 21503272 Authors: Zafar SF, Heilbrun LK, Vishnu P, Jasti P, Venkatramanamoorthy R, Ding L, Lorusso PM, Heath EI.

1. 添加医学顾问微信，扫描☟二维码

2. 备注【癌种】进病友群

扫描预约专家问诊

专家科普

同类全球会诊
合作伙伴：